BHC
BHC clinical trials: Bausch Health Companies Inc.
Every trial on ClinicalTrials.gov where Bausch Health Companies Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 292
- Trials linked
- 218
- As lead sponsor
- 74
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
BHC on the catalyst calendar · BHC registry changes
- Primary completion Dec 23, 2025ActualPhase 3NCT05071716Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisBausch Health Americas, Inc. · Hepatic EncephalopathyCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2027Sponsor estimatePhase 3NCT07428538Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)Bausch Health Americas, Inc. · HepatitisRecruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 24, 2026ActualNo phase registeredNCT07214272A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin ResurfacingBausch Health Americas, Inc. · Skin ResurfacingActive, not recruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 22, 2026ActualNo phase registeredNCT07187297A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency TreatmentBausch Health Americas, Inc. · WrinkleActive, not recruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 18, 2027Sponsor estimatePhase 2NCT07723924This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based...Bausch Health Americas, Inc. · Functional Constipation (FC)Active, not recruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 24, 2026ActualPhase 3NCT05297448Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisBausch Health Americas, Inc. · Hepatic EncephalopathyCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2030Sponsor estimatePhase 4NCT05976802Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17...Bausch Health Americas, Inc. · Ulcerative ColitisNot yet recruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 7, 2020ActualPhase 3NCT03664752Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Participants With Acne VulgarisBausch Health Americas, Inc. · Acne VulgarisCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 22, 2017ActualPhase 3NCT02932306Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Participants With Acne VulgarisBausch Health Americas, Inc. · AcneCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 15, 2017ActualPhase 3NCT02515097Safety and Efficacy of IDP-122 in Participants With Plaque PsoriasisBausch Health Americas, Inc. · Plaque PsoriasisCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 9, 2016ActualPhase 3NCT02462122Safety and Efficacy of IDP-118 in Participants With Plaque PsoriasisBausch Health Americas, Inc. · Plaque PsoriasisCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2026Sponsor estimatePhase 4NCT03987763A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisBausch Health Americas, Inc. · PsoriasisActive, not recruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 5, 2025ActualNo phase registeredNCT05132231Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work ProductivityBausch Health Americas, Inc. · PsoriasisActive, not recruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2016ActualPhase 3NCT02387359The Plecanatide Irritable Bowel Syndrome With Constipation Safety and Efficacy Study (IBS-C)Bausch Health Americas, Inc. · Irritable Bowel Syndrome Characterized by ConstipationCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2030Sponsor estimatePhase 4NCT02129751Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive DisorderBausch Health Americas, Inc. · Major Depressive DisorderNot yet recruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 3, 2026ActualNo phase registeredNCT07205107Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne VulgarisBausch Health Americas, Inc. · Acne VulgarisCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 20, 2027Sponsor estimatePhase 4NCT07285785Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute DiarrheaBausch Health Americas, Inc. · DiarrheaRecruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 4NCT07524946Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoBausch Health Americas, Inc. · Acne VulgarisRecruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 6, 2026ActualPhase 4NCT03988439A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisBausch Health Americas, Inc. · PsoriasisCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 25, 2024ActualPhase 2NCT03596905Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)Bausch Health Americas, Inc. · Irritable Bowel Syndrome With ConstipationCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 28, 2022ActualPhase 2NCT04892706Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle GelBausch Health Americas, Inc. · Acne VulgarisCompletedBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2021Sponsor estimatePhase 1NCT04356677Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19_#2Bausch Health Americas, Inc. · COVID19WithdrawnBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 4NCT04314375Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17...Bausch Health Americas, Inc. · Ulcerative ColitisRecruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 10, 2030Sponsor estimateNo phase registeredNCT03254667LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe PsoriasisBausch Health Americas, Inc. · PsoriasisEnrolling by invitationBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2028Sponsor estimatePhase 4NCT03240809An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric SubjectsBausch Health Americas, Inc. · PsoriasisActive, not recruitingBHCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 267 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner